Atlas FDA

Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum.

FDA device recall Z-0827-2015 · posted 2014-12-18 · Terminated

Recall details

Recalling firm
JAS Diagnostics Inc.
Reason for recall
Product is not performing according to specifications. Control 2 does not consistently recover within its assigned range.
Action taken
On October 23, 2014, JAS Diagnostics, Inc. sent out an IMPORTANT PRODUCT RECALL INFORMATION letter asking its consignees to discontinue use of the Glucose Hexokinase lots immediately. Customers are to contact the Service Department at 305-748-2762 or 305-748-2763 for information regarding reimbursement. Also, customers are to complete the attached Certificate of Destruction and return the document to JAS Diagnostics.
Root cause
Under Investigation by firm
Status
Terminated
Product code
CFR
Quantity affected
390
Distribution
Worldwide Distribution -- US, including the states of NV, TN, TX, FL, GA, NY, NC, CA, MN, OR and Puerto Rico; and, the countries of France, Jamaica, Haiti, Cayman Islands, Trinidad & Tobago, and Ghana
Date initiated
2014-10-23
Date posted
2014-12-18
Date terminated
2015-02-26
Location
Miami Lakes, FL

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
GLUCOSE (HEXOKINASE) (K011900)Jas Diagnostics, Inc.2001-07-31